Breaking News

Chinese Drugmaker Expands Pharma Production Facility

Changzhou Qianhong Bio-pharma starts construction of RMB 1 billion facility for polysaccharides and enzyme drugs

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Changzhou Qianhong Bio-pharma started the second phase of construction at its pharmaceuticals production facility in Changzhou National Hi-Tech District. With an investment of 1 billion yuan (~$150 million), phase two adds 200 million tablets and 60 million injections to production as well as making molecular diagnosis reagents available for use by 20 million people. Changzhou government officials including Liang Yibo and Yan Jun took part in the groundbreaking ceremony.   Changzhou Qianhong B...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters